JP Morgan Chase
TELO icon

JP Morgan Chase’s Telomir Pharmaceuticals TELO Stock Holding History

JP Morgan Chase’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138 Hold
121
– – ﹤0.01% 7288
2025
Q4 		$161 Buy
+121
New +$175 ﹤0.01% 7185
2025
Q3 		– Sell
-1,762
Closed -$2.2K – 7771
2025
Q2 		$2.2K Sell
1,762
-7,519
-81% -$17.4K ﹤0.01% 6526
2025
Q1 		$30K Sell
9,281
-32,163
-78% -$141K ﹤0.01% 6033
2024
Q4 		$171K Buy
41,444
+37,980
+1,096% +$179K ﹤0.01% 5547
2024
Q3 		$22.2K Buy
3,464
+1,414
+69% +$6.89K ﹤0.01% 6216
2024
Q2 		$9.86K Sell
2,050
-555
-21% -$3.46K ﹤0.01% 6268
2024
Q1 		$13.6K Buy
+2,605
New +$19.7K ﹤0.01% 6298

Other funds holding TELO

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return

JP Morgan Chase's TELO Position: Q1 2026 in Review

JP Morgan Chase held its Telomir Pharmaceuticals (TELO) position steady in Q1 2026 at 121 shares worth $138. The position accounts for ﹤0.01% of the portfolio, ranked #7288.

JP Morgan Chase first reported a position in TELO in Q1 2024 and has held it in 8 quarters since. The position peaked at $171K in Q4 2024. 27 funds tracked by Wall St. Rank hold TELO as of Q1 2026.

  • JP Morgan Chase held 121 shares of Telomir Pharmaceuticals worth $138 as of Q1 2026.
  • JP Morgan Chase left its Telomir Pharmaceuticals share count unchanged in Q1 2026.
  • Telomir Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7288 holding.
  • JP Morgan Chase first reported a position in Telomir Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • JP Morgan Chase's Telomir Pharmaceuticals position peaked at $171K in Q4 2024.
  • 27 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.